UB Paderborn / Katalog / Suche / in CDI

1 – 21 von 21

Sortiert nach

Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300

Annals of oncology, 2018-10, Vol.29 (10), p.2052-2060

2018

Link zum Volltext

Verfügbarkeit prüfen

Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK 0205

British journal of cancer, 2013-09, Vol.109 (6), p.1408-1413

2013

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer

The New England journal of medicine, 2021-04, Vol.384 (13), p.1191-1203

2021

Link zum Volltext

Verfügbarkeit prüfen

Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial

Annals of oncology, 2019-11, Vol.30 (11), p.1796-1803

2019

Link zum Volltext

Verfügbarkeit prüfen

Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma: results from OPTIMUM, a randomized trial

Haematologica (Roma), 2012-05, Vol.97 (5), p.784-796

2012

Link zum Volltext

Verfügbarkeit prüfen

Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer

British journal of cancer, 2010-02, Vol.102 (3), p.506-512

2010

Link zum Volltext

Verfügbarkeit prüfen

Deterioration in quality of life (QoL) in patients with malignant ascites: results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone

Annals of oncology, 2012-08, Vol.23 (8), p.1979-1985

2012

Link zum Volltext

Verfügbarkeit prüfen

Lumbar Bone Marrow Microcirculation Measurements from Dynamic Contrast-Enhanced Magnetic Resonance Imaging Is a Predictor of Event-Free Survival in Progressive Multiple Myeloma

Clinical cancer research, 2007-01, Vol.13 (2), p.475-481

2007

Link zum Volltext

Verfügbarkeit prüfen

Prediction model of lymph node metastasis in superficial esophageal adenocarcinoma and squamous cell cancer including D2-40 immunostaining

Journal of surgical oncology, 2009-09, Vol.100 (3), p.191-198

2009

Link zum Volltext

Verfügbarkeit prüfen

The application of Gadopentate-Dimeneglumin has no impact on progression free and overall survival as well as renal function in patients with monoclonal plasma cell disorders if general precautions are taken

European radiology, 2015-03, Vol.25 (3), p.745-750

2015

Link zum Volltext

Verfügbarkeit prüfen

Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trials

British journal of cancer, 2009-12, Vol.101 (11), p.1846-1852

2009

Link zum Volltext

Verfügbarkeit prüfen

Clinical evidence for immunomodulation induced by high-dose melphalan and autologous blood stem cell transplantation as cause for complete clinical remission of multiple myeloma-associated cryoglobulin-vasculitis

International journal of hematology, 2008-11, Vol.88 (4), p.454-456

2008

Link zum Volltext

Verfügbarkeit prüfen

Bone marrow microcirculation analysis in multiple myeloma by contrast‐enhanced dynamic magnetic resonance imaging

International journal of cancer, 2001-09, Vol.93 (6), p.862-868

2001

Link zum Volltext

Verfügbarkeit prüfen

Efficient mobilization of peripheral blood stem cells following CAD chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma

Bone marrow transplantation (Basingstoke), 2007-06, Vol.39 (12), p.743-750

2007

Link zum Volltext

Verfügbarkeit prüfen

Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer

BMC cancer, 2004-07, Vol.4 (1), p.38-38, Article 38

2004

Link zum Volltext

Verfügbarkeit prüfen

The outcome of autologous stem cell transplantation in patients with plasma cell disorders and dialysis-dependent renal failure

Haematologica (Roma), 2006-11, Vol.91 (11), p.1555-1558

2006

Link zum Volltext

Verfügbarkeit prüfen

Gemcitabine, oxaliplatin and weekly high-dose 5-FU as 24-h infusion in chemonaive patients with advanced or metastatic pancreatic adenocarcinoma: a multicenter phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

Annals of oncology, 2007-01, Vol.18 (1), p.82-87

2007

Link zum Volltext

Verfügbarkeit prüfen

Development of leukocytoclastic vasculitis in a patient with multiple myeloma during treatment with thalidomide

Annals of hematology, 2004-07, Vol.83 (7), p.467-470

2004

Link zum Volltext

Verfügbarkeit prüfen

Polymorphisms of the tumor necrosis factor-α gene promoter predict for outcome after thalidomide therapy in relapsed and refractory multiple myeloma

Blood, 2002-09, Vol.100 (6), p.2263-2265

2002

Link zum Volltext

Verfügbarkeit prüfen

Conception and evaluation of a simple fitness test

Schweizerische Zeitschrift fur Sportmedizin, 1975, Vol.23 (2), p.57

1975

Link zum Volltext

Verfügbarkeit prüfen

1 – 21 von 21

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

KollektionMEDLINE

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(21)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(21)
Male
(21)
Aged
(19)
Female
(18)
Life Sciences & Biomedicine
(18)
Science & Technology
(18)
Adult
(15)
Oncology
(14)
Biological And Medical Sciences
(12)
Medical Sciences
(12)
Aged, 80 And Over
(9)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(8)
Multiple Myeloma
(8)
Disease-Free Survival
(7)
Prognosis
(7)
Treatment Outcome
(7)
Adenocarcinoma - Drug Therapy
(5)
Chemotherapy
(5)
Disease Progression
(5)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300

Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK 0205

Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer

Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial

Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma: results from OPTIMUM, a randomized trial

Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer

Deterioration in quality of life (QoL) in patients with malignant ascites: results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone

Lumbar Bone Marrow Microcirculation Measurements from Dynamic Contrast-Enhanced Magnetic Resonance Imaging Is a Predictor of Event-Free Survival in Progressive Multiple Myeloma

Prediction model of lymph node metastasis in superficial esophageal adenocarcinoma and squamous cell cancer including D2-40 immunostaining

The application of Gadopentate-Dimeneglumin has no impact on progression free and overall survival as well as renal function in patients with monoclonal plasma cell disorders if general precautions are taken

Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trials

Clinical evidence for immunomodulation induced by high-dose melphalan and autologous blood stem cell transplantation as cause for complete clinical remission of multiple myeloma-associated cryoglobulin-vasculitis

Bone marrow microcirculation analysis in multiple myeloma by contrast‐enhanced dynamic magnetic resonance imaging

Efficient mobilization of peripheral blood stem cells following CAD chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma

Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer

The outcome of autologous stem cell transplantation in patients with plasma cell disorders and dialysis-dependent renal failure

Gemcitabine, oxaliplatin and weekly high-dose 5-FU as 24-h infusion in chemonaive patients with advanced or metastatic pancreatic adenocarcinoma: a multicenter phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

Development of leukocytoclastic vasculitis in a patient with multiple myeloma during treatment with thalidomide

Polymorphisms of the tumor necrosis factor-α gene promoter predict for outcome after thalidomide therapy in relapsed and refractory multiple myeloma

Conception and evaluation of a simple fitness test

Aktive Filter

Suchergebnisse filtern